Agonist diversity in 5-HT2C receptor-mediated weight control in rats (original) (raw)

• Akiyoshi J, Nishizono A, Yamada K, Nagayama H, Mifune K, Fujii I (1995) Rapid desensitization of serotonin 5-HT(2C) receptor-stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT(2C) receptors. J Neurochem 64(6):2473–2479
  CAS PubMed Google Scholar
• Aulakh CS, Mazzola-Pomietto P, Hill JL, Murphy DL (1994) Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats. J Pharmacol Exp Ther 271(1):143–148
  CAS PubMed Google Scholar
• Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38(8):1083–1152
  Article CAS PubMed Google Scholar
• Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54(1):94–104
  CAS PubMed Google Scholar
• Boess FG, Martin IL (1994) Molecular biology of 5-HT receptors. Neuropharmacology 33(3–4):275–317
  Article CAS PubMed Google Scholar
• Briddon SJ, Leslie RA, Elliott JM (1998) Comparative desensitization of the human 5-HT2A and 5-HT2C receptors expressed in the human neuroblastoma cell line SH-SY5Y. Br J Pharmacol 125(4):727–734
  CAS PubMed Google Scholar
• Clarke WP, Bond RA (1998) The elusive nature of intrinsic efficacy. Trends Pharmacol Sci 19(7):270–276
  Article CAS PubMed Google Scholar
• Clifton PG, Lee MD, Dourish CT (2000) Similarities in the action of Ro 60-0175, a 5-HT(2c) receptor agonist, and d-fenfluramine on feeding patterns in the rat. Psychopharmacologia 152(3):256–267
  Article CAS Google Scholar
• Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL, Gettys TW (1994) Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8(4):518–527
  Article CAS PubMed Google Scholar
• Collins S, Daniel KW, Rohlfs EM (1999) Depressed expression of adipocyte beta-adrenergic receptors is a common feature of congenital and diet-induced obesity in rodents. Int J Obes Related Metab Disorders, J Int Assoc Study Obes 23(7):669–677
  Google Scholar
• Evans BA, Papaioannou M, Anastasopoulos F, Summers RJ (1998) Differential regulation of beta3-adrenoceptors in gut and adipose tissue of genetically obese (ob/ob) C57BL/6J-mice. Br J Pharmacol 124(4):763–771
  CAS PubMed Google Scholar
• Fone KCF, Austin RH, Topham IA, Kennett GA, Punhani T (1998) Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT(2C) receptor levels in the rat. Br J Pharmacol 123(8):1707–1715
  CAS PubMed Google Scholar
• Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP (2000) Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab 2(3):175–187
  Article CAS PubMed Google Scholar
• Grossman SP, Grossman L (1982) Iontophoretic injections of kainic acid into the rat lateral hypothalamus: effects on ingestive behavior. Physiol Behav 29(3):553–559
  Article CAS PubMed Google Scholar
• Grottick AJ, Corrigall WA, Higgins GA (2001) Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 157(3):292–298
  Article CAS PubMed Google Scholar
• Grujic D, Susulic VS, Harper ME, Himms-Hagen J, Cunningham BA, Corkey BE, Lowell BB (1997) Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J Biol Chem 272(28):17686–17693
  Article CAS PubMed Google Scholar
• Hayashi A, Sonoda R, Kimura Y, Takasu T, Suzuki M, Sasamata M, Miyata K (2004) Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats. Brain Res 1011(2):221–227
  Article CAS PubMed Google Scholar
• Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, Elmquist JK (2002) Activation of central melanocortin pathways by fenfluramine. Science 297(5581):609–611
  Article CAS PubMed Google Scholar
• Kasser TR, Harris RBS, Martin RJ (1989) Level of satiety: in vitro energy metabolism in brain during hypophagic and hyperphagic body weight recovery. Am J Physiol Regul Integr Comp Physiol 257(6):26/6
  Google Scholar
• Kenakin T (1995) Agonist-receptor efficacy II: Agonist trafficking of receptor signals. Trends Pharmacol Sci 16(7):232–238
  Article CAS PubMed Google Scholar
• Kennett GA, Curzon G (1988a) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94(1):137–147
  CAS PubMed Google Scholar
• Kennett GA, Curzon G (1988b) Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacologia 96(1):93–100
  CAS Google Scholar
• Kennett GA, Ainsworth K, Trail B, Blackburn TP (1997) BW 723C86, a 5-HT(2B) receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology 36(2):233–239
  Article CAS PubMed Google Scholar
• Kennett G, Lightowler S, Trail B, Bright F, Bromidge S (2000) Effects of RO60-0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety. Eur J Pharmacol 387(2):197–204
  Article CAS PubMed Google Scholar
• Kimura Y, Hatanaka K, Naito Y, Maeno K, Koakutsu A, Wanibuchi F, Yamaguchi T (2003) Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist. Eur J Pharmacol 483:37–43
  Article Google Scholar
• Leung WYS, Thomas GN, Chan JCN, Tomlinson B (2003) Weight management and current options in pharmacotherapy: orlistat and sibutramine. Clin Ther 25(1):58–80
  Article CAS PubMed Google Scholar
• Martin GR, Humphrey PPA (1994) Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology 33(3–4):261–273
  Article CAS PubMed Google Scholar
• Martin JR, Bos M, Jenck F, Moreau J-L, Mutel V, Sleight AJ, Wichmann J, Andrews JS, Berendsen HHG, Broekkamp CLE, Ruigt GSF, Kohler C, Van Delft AML (1998) 5-HT(2C) receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286(2):913–924
  CAS PubMed Google Scholar
• Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Murphy DL (1996) Evidence that _m_-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacologia 123(4):333–339
  CAS Google Scholar
• McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD (2000) Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Int Med 160(14):2185–2191
  Article CAS Google Scholar
• Mystkowski P, Seeley RJ, Hahn TM, Baskin DG, Havel PJ, Matsumoto AM, Wilkinson CW, Peacock-Kinzig K, Blake KA, Schwartz MW (2000) Hypothalamic melanin-concentrating hormone and estrogen-induced weight loss. J Neurosci 20(22):8637–8642
  CAS Google Scholar
• Nonogaki K, Memon RA, Grunfeld C, Feingold KR, Tecott LH (2002) Altered gene expressions involved in energy expenditure in 5-HT(2C) receptor mutant mice. Biochem Biophy Res Commun 295(2):249–254
  Article CAS Google Scholar
• Porter RHP, Malcolm CS, Allen NH, Lamb H, Revell DF, Sheardown MJ (2001) Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells. Biochem Pharmacol 62(4):431–438
  Article CAS PubMed Google Scholar
• Schreiber R, Selbach K, Asmussen M, Hesse D, De Vry J (2000) Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats. Pharmacol Biochem Behav 67(2):291–305
  Article CAS PubMed Google Scholar
• Shiraishi T, Simpson A (1982) Lateral hypothalamus neuron responses to electroosmotic 2-deoxy-d-glucose. Brain Res Bull 8(6):645–651
  Article CAS PubMed Google Scholar
• Stout BD, Clarke WP, Berg KA (2002) Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence. J Pharmacol Exp Ther 302(3):957–962
  Article CAS PubMed Google Scholar
• Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT(2C) serotonin receptors. Nature 374(6522):542–546
  Article CAS PubMed Google Scholar
• Tuomisto JT, Pohjanvirta R, Unkila M, Tuomisto J (1995) 2,3,7,8-Tetrachlorodibenzo-_p_-dioxin-induced anorexia and wasting syndrome in rats: aggravation after ventromedial hypothalamic lesion. Eur J Pharmacol Environ Toxicol Pharmacol Sect 293(4):309–317
  Article CAS Google Scholar
• Vickers SP, Benwell KR, Porter RH, Bickerdike MJ, Kennett GA, Dourish CT (2000) Comparative effects of continuous infusion of mCPP, Ro60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol 130(6):1305–1314
  CAS PubMed Google Scholar
• Vickers SP, Dourish CT, Kennett GA (2001) Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology 41(2):200–209
  Article CAS PubMed Google Scholar
• Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT, Kennett GA (2003) Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology 167(3):274–280
  CAS PubMed Google Scholar
• Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1988) The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol Biochem Behav 30(2):451–456
  Article CAS PubMed Google Scholar